organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 21, 2015 Filed Dec 22, 2015 19:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 205,000 | $86.00 | $17,630,000.00 |
DisclosureSEC source: 0001209191-15-086568 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,860,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.50 to $86.43, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 15, 2015 Filed Dec 16, 2015 20:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 215,000 | $85.60 | $18,402,925.00 |
DisclosureSEC source: 0001209191-15-085541 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,065,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.12 to $85.955, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 02, 2015 Filed Dec 3, 2015 18:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 64,715 | $85.58 | $5,538,439.13 |
DisclosureSEC source: 0001209191-15-083119 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,280,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.43 to $86.08, inclusive. Read SEC document |
| December 02, 2015 Filed Dec 3, 2015 18:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 145,285 | $84.87 | $12,330,628.52 |
DisclosureSEC source: 0001209191-15-083119 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,345,519 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.43 to $85.425, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 18:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,300 | $85.32 | $1,561,429.20 |
DisclosureSEC source: 0001209191-15-081732 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,490,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.145 to $85.495, inclusive. Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 18:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 186,700 | $84.47 | $15,769,802.20 |
DisclosureSEC source: 0001209191-15-081732 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,509,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.12 to $85.11, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 29, 2015 Filed Oct 30, 2015 19:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,500 | $83.43 | $876,025.50 |
DisclosureSEC source: 0001209191-15-077406 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,695,804 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.35 to $83.55, inclusive. Read SEC document |
| October 29, 2015 Filed Oct 30, 2015 19:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 92,269 | $82.75 | $7,635,536.56 |
DisclosureSEC source: 0001209191-15-077406 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,706,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.35 to $83.34, inclusive. Read SEC document |
| October 29, 2015 Filed Oct 30, 2015 19:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 97,231 | $81.70 | $7,944,161.62 |
DisclosureSEC source: 0001209191-15-077406 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,798,573 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.315 to $82.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| October 09, 2015 Filed Oct 13, 2015 18:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,405 | $86.44 | $640,110.42 |
DisclosureSEC source: 0001209191-15-075203 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,895,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.33 to $86.50, inclusive. Read SEC document |
| October 09, 2015 Filed Oct 13, 2015 18:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 207,595 | $85.84 | $17,819,332.02 |
DisclosureSEC source: 0001209191-15-075203 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,903,209 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.33 to $86.31, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 05, 2015 Filed Oct 6, 2015 20:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,300 | $87.77 | $991,812.30 |
DisclosureSEC source: 0001209191-15-074336 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,110,804 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.62 to $87.88, inclusive. Read SEC document |
| October 05, 2015 Filed Oct 6, 2015 20:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 53,940 | $86.93 | $4,689,112.08 |
DisclosureSEC source: 0001209191-15-074336 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,122,104 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.62 to $87.61, inclusive. Read SEC document |
| October 05, 2015 Filed Oct 6, 2015 20:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 194,760 | $86.25 | $16,798,634.28 |
DisclosureSEC source: 0001209191-15-074336 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,176,044 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.61 to $86.60, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| September 18, 2015 Filed Sep 21, 2015 18:09 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,636 | $89.66 | $3,733,208.67 |
DisclosureSEC source: 0001209191-15-071571 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,370,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.42 to $90.23, inclusive. Read SEC document |
| September 18, 2015 Filed Sep 21, 2015 18:09 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 208,364 | $88.92 | $18,527,101.79 |
DisclosureSEC source: 0001209191-15-071571 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,412,440 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.42 to $89.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 10, 2015 Filed Jun 11, 2015 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,494 | $83.43 | $208,064.44 |
DisclosureSEC source: 0001209191-15-052256 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,620,804 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.42 to $83.45, inclusive. Read SEC document |
| June 10, 2015 Filed Jun 11, 2015 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 85,926 | $82.89 | $7,121,976.51 |
DisclosureSEC source: 0001209191-15-052256 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,623,298 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.42 to $83.405, inclusive. Read SEC document |
| June 10, 2015 Filed Jun 11, 2015 19:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 121,580 | $82.02 | $9,972,477.92 |
DisclosureSEC source: 0001209191-15-052256 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,709,224 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.42 to $82.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 04, 2015 Filed Jun 5, 2015 19:28 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,700 | $78.52 | $369,058.10 |
DisclosureSEC source: 0001209191-15-050515 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,830,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.50 to $78.58, inclusive. Read SEC document |
| June 04, 2015 Filed Jun 5, 2015 19:28 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 195,300 | $77.89 | $15,210,940.50 |
DisclosureSEC source: 0001209191-15-050515 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,835,504 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.49 to $78.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 01, 2015 Filed Jun 2, 2015 17:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 220,000 | $79.36 | $17,460,080.00 |
DisclosureSEC source: 0001209191-15-048756 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,030,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.87 to $79.84, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 20, 2015 Filed May 21, 2015 19:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 190,000 | $73.43 | $13,951,320.00 |
DisclosureSEC source: 0001209191-15-045306 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,250,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.19 to $73.69, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 15, 2015 Filed May 18, 2015 17:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $72.83 | $14,566,400.00 |
DisclosureSEC source: 0001209191-15-043646 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,440,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.60 to $73.03, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 08, 2015 Filed May 11, 2015 17:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 195,000 | $73.28 | $14,289,795.00 |
DisclosureSEC source: 0001209191-15-040977 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,640,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.01 to $73.69, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 01, 2015 Filed May 4, 2015 18:58 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $73.09 | $14,617,600.00 |
DisclosureSEC source: 0001209191-15-038352 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,835,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.87 to $73.305, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 30, 2015 Filed Mar 31, 2015 17:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,000 | $73.94 | $13,308,660.00 |
DisclosureSEC source: 0001209191-15-030360 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,035,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.84 to $74.08, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 16:50 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,100 | $77.39 | $781,628.90 |
DisclosureSEC source: 0001209191-15-028701 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,215,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.355 to $77.43, inclusive. Read SEC document |
| March 23, 2015 Filed Mar 24, 2015 16:50 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 179,900 | $76.95 | $13,842,405.50 |
DisclosureSEC source: 0001209191-15-028701 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,225,904 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.36 to $77.35, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 04, 2014 Filed Dec 5, 2014 19:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 190,000 | $71.92 | $13,664,800.00 |
DisclosureSEC source: 0001209191-14-073334 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,405,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.445 to $72.40, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 02, 2014 Filed Dec 3, 2014 16:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 38,765 | $70.52 | $2,733,707.80 |
DisclosureSEC source: 0001209191-14-072576 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,595,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.39 to $70.76, inclusive. Read SEC document |
| December 02, 2014 Filed Dec 3, 2014 16:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 141,235 | $70.03 | $9,890,687.05 |
DisclosureSEC source: 0001209191-14-072576 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,634,569 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.39 to $70.38, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 13, 2014 Filed Nov 14, 2014 16:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $67.73 | $13,546,000.00 |
DisclosureSEC source: 0001209191-14-068726 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,775,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.42 to $68.00, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 19:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,000 | $67.00 | $12,060,000.00 |
DisclosureSEC source: 0001209191-14-066951 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,975,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.76 to $67.46, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 31, 2014 Filed Nov 3, 2014 20:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 9,399 | $67.01 | $629,826.99 |
DisclosureSEC source: 0001209191-14-065770 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,155,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.93 to $67.10, inclusive. Read SEC document |
| October 31, 2014 Filed Nov 3, 2014 20:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,601 | $66.37 | $11,986,488.37 |
DisclosureSEC source: 0001209191-14-065770 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,165,203 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.93 to $66.91, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 30, 2014 Filed Oct 31, 2014 19:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,900 | $66.94 | $328,006.00 |
DisclosureSEC source: 0001209191-14-065535 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,345,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.93 to $66.96, inclusive. Read SEC document |
| October 30, 2014 Filed Oct 31, 2014 19:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 170,100 | $66.57 | $11,323,557.00 |
DisclosureSEC source: 0001209191-14-065535 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,350,704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.93 to $66.92, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 06, 2014 Filed Oct 7, 2014 18:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $65.63 | $13,782,300.00 |
DisclosureSEC source: 0001209191-14-062287 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,520,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.40 to $65.94, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 17:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $65.07 | $13,014,000.00 |
DisclosureSEC source: 0001209191-14-060450 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,730,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.84 to $65.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 10, 2014 Filed Sep 11, 2014 16:07 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $64.77 | $13,601,700.00 |
DisclosureSEC source: 0001209191-14-057445 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,930,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.59 to $64.91, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 03, 2014 Filed Sep 4, 2014 15:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $63.99 | $12,798,000.00 |
DisclosureSEC source: 0001209191-14-055790 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,140,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.805 to $64.13, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 29, 2014 Filed Jul 30, 2014 19:01 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 300 | $63.64 | $19,092.00 |
DisclosureSEC source: 0001209191-14-049518 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,340,804 F2 · price: The shares reported in Column 4 were sold at $63.64. Read SEC document |
| July 29, 2014 Filed Jul 30, 2014 19:01 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 249,700 | $63.03 | $15,738,591.00 |
DisclosureSEC source: 0001209191-14-049518 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,341,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.64 to $63.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 01, 2014 Filed Jul 2, 2014 19:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 235,000 | $62.30 | $14,640,500.00 |
DisclosureSEC source: 0001209191-14-045082 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,590,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.02 to $62.545, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 25, 2014 Filed Jun 26, 2014 18:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 400 | $63.10 | $25,240.00 |
DisclosureSEC source: 0001209191-14-043780 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,825,804 F2 · price: The shares reported in Column 4 were sold at $63.10. Read SEC document |
| June 25, 2014 Filed Jun 26, 2014 18:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 244,600 | $62.68 | $15,331,528.00 |
DisclosureSEC source: 0001209191-14-043780 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,826,204 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.07 to $63.06, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 20, 2014 Filed Jun 23, 2014 19:01 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 85,600 | $61.95 | $5,302,920.00 |
DisclosureSEC source: 0001209191-14-043080 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,070,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.80 to $62.14, inclusive. Read SEC document |
| June 20, 2014 Filed Jun 23, 2014 19:01 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 144,400 | $61.31 | $8,853,164.00 |
DisclosureSEC source: 0001209191-14-043080 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,156,404 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.80 to $61.79, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 20, 2014 Filed Jun 25, 2014 20:28 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 85,600 | $61.96 | $5,303,776.00 |
DisclosureSEC source: 0000911916-14-000098 · edgar.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,070,804 F3 · price: This Amendment is being filed to correct the weighted average price reported in Column 4 of Table I in the Form 4 filed on June 23, 2014, which inadvertantly reported the weighted average price as $61.95. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.80 to $62.14, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.